CHIPOpt

Pricing Availability   Qty
Description: CHIP/STUB1 E3 ligase inhibitor
Purity: ≥95% (HPLC)
Datasheet
Citations
Reviews
Literature (3)

Biological Activity for CHIPOpt

CHIPOpt is a CHIP/STUB1 E3 ligase inhibitor. In vitro, CHIPOpt decreases phosphorylated tau ubiquitination, with little effect on unmodified tau. In Thioflavin T assays, CHIPOpt inhibits the ability of CHIP to suppress phosphorylated tau aggregation. FITC-CHIPOpt (Cat. No. 8045), a fluorescent CHIPOpt, is also available.

Technical Data for CHIPOpt

M. Wt 757.84
Formula C39H47N7O9
Sequence LWWPD

(Modification: Leu-1 = N-terminal Ac)

Storage Store at -20°C
Purity ≥95% (HPLC)
InChI Key NAUYSEKQVONAJC-ZTTXAYQISA-N
Smiles O=C(N[C@@H](CC(C)C)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC3=CNC4=CC=CC=C34)C(N5[C@@H](CCC5)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)C

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for CHIPOpt

Solubility Soluble to 2 mg/ml in 0.01M PBS

References for CHIPOpt

References are publications that support the biological activity of the product.

Nadel et al (2023) The E3 ubiquitin ligase, CHIP/STUB1, inhibits aggregation of phosphorylated proteoforms of microtubule-associated protein tau (MAPT). J.Mol.Biol. 435 168026 PMID: 37330289

Ravalin et al (2019) Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases. Nat.Chem.Biol. 15 786 PMID: 31320752


If you know of a relevant reference for CHIPOpt, please let us know.

View Related Products by Product Action

View all Ubiquitin E3 Ligase Inhibitors

Keywords: CHIPOpt, CHIPOpt supplier, CHIPOpt, ubiquitin, ligase, inhibitor, inhibitors, inhibit, ligases, ubiquitination, in, vitro, phosphorylated, tau, aggregation, Ubiquitin, E3, Ligases, 8044, Tocris Bioscience

Citations for CHIPOpt

Citations are publications that use Tocris products.

Currently there are no citations for CHIPOpt. Do you know of a great paper that uses CHIPOpt from Tocris? Please let us know.

Reviews for CHIPOpt

There are currently no reviews for this product. Be the first to review CHIPOpt and earn rewards!

Have you used CHIPOpt?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


TPD and Induced Proximity Research Product Guide

TPD and Induced Proximity Research Product Guide

This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:

  • Active Degraders
  • TAG Degradation Platform
  • Degrader Building Blocks
  • Assays for Protein Degradation
  • Induced Proximity Tools
Programmed Cell Death Poster

Programmed Cell Death Poster

There are two currently recognized forms of programmed cell death: apoptosis and necroptosis. This poster summarizes the signaling pathways involved in apoptosis, necroptosis and cell survival following death receptor activation, and highlights the influence of the molecular switch, cFLIP, on cell fate.

Targeted Protein Degradation Poster

Targeted Protein Degradation Poster

Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia